Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study

The use of mRNA COVID-19 vaccine can on rare occasions cause life-threatening, fulminant myopericarditis. This case report demonstrates previously reported benefit of early use of venoarterial extracorporeal membrane oxygenation mechanical assistance and supports the use of intravenous highly purifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Montarello, Natalie L., Wong, Hao Zheng, Jeffries, Ashlee, Perkins, Griffith B., Hissaria, Pravin, Stokes, Michael B., Raith, Eamon, Teo, Karen, Bradley, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581261/
https://www.ncbi.nlm.nih.gov/pubmed/37876367
http://dx.doi.org/10.1016/j.ccrj.2023.06.005
Descripción
Sumario:The use of mRNA COVID-19 vaccine can on rare occasions cause life-threatening, fulminant myopericarditis. This case report demonstrates previously reported benefit of early use of venoarterial extracorporeal membrane oxygenation mechanical assistance and supports the use of intravenous highly purified immunoglobulin pharmacotherapy to help achieve a good clinical outcome.

Ejemplares similares